Bepotastine
Chemical compound / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Bepotastine?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Bepotastine (Talion, Bepreve) is a 2nd generation antihistamine.[2] It was approved in Japan for use in the treatment of allergic rhinitis and urticaria/pruritus in July 2000, and January 2002, respectively. It is marketed in the United States as an eye drop under the brand name Bepreve, by ISTA Pharmaceuticals, a subsidiary of Bausch + Lomb.[citation needed]
Quick Facts Clinical data, Trade names ...
Clinical data | |
---|---|
Trade names | Bepreve |
AHFS/Drugs.com | International Drug Names |
MedlinePlus | a610012 |
Routes of administration | Oral, eye drops |
ATC code |
|
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | High (oral) Minimal (topical) |
Protein binding | ~55% |
Excretion | Renal (75–85 |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C21H25ClN2O3 |
Molar mass | 388.89 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Close